CY-503

· Cytavis Biopharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CY-503, covering 2013-07-10 to 2013-07-10. Get the full timeline:

Most recent: Clinical Trial Update: CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer [Phase 2]